Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ferrexpo cancels interim dividend

(Sharecast News) - Iron ore pellet producer Ferrexpo said on Tuesday that it was cancelling its interim dividend just days before it was due to be paid out, following a claim against its Ukrainian subsidiary. The company said it has decided not to go ahead with the 3.3 cents per share dividend following "unexpected" events in Ukraine relating to a claim against one of its subsidiaries, Ferrexpo Poltava Mining (FPM), which it disclosed at the end of last month.

Ferrexpo filed a cassation appeal to the Supreme Court in Ukraine on 30 January and an application to suspend enforcement of the decision of the Eastern Economic Court of Appeal in Kharkiv.

It said that until the Supreme Court has considered the application there is a risk of enforcement. However, Ferrexpo insisted the claims were "without merit" and said it had "compelling arguments" to vigorously defend its position.

"The board has reconsidered the interim dividend and decided to withdraw it. The board aims to resume its focus on shareholder returns at the appropriate time."

At 1310 GMT, the shares were down 5% at 76.85p.

Share this article

Related Sharecast Articles

Berenberg names Admiral among top picks in European insurance
(Sharecast News) - Berenberg analysts have named UK-listed motor insurer Admiral among their top picks in the European insurance sector.
Orosur Mining consultant exercises stock options
(Sharecast News) - Orosur Mining announced the issue of 83,333 new shares on Tuesday, following the exercise of stock options by a company consultant at an exercise price of six Canadian cents per share.
Helium One reports encouraging flow testing at Jackson-29
(Sharecast News) - Helium One Global reported encouraging flow test results from the Jackson-29 well at the Galactica Project in Colorado on Tuesday, where it holds a 50% working interest in a joint venture with Blue Star Helium.
Roche to spend $50bn on US manufacturing, R&D sites
(Sharecast News) - Swiss healthcare giant Roche announced on Tuesday that it is planning to spend $50bn in pharmaceuticals and diagnostics in the US over the next five years.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.